Health ❯Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Drug Safety Clinical Trials Weight Loss Weight Loss Drugs Drug Regulation Cancer Treatment Obesity Treatment

Baxdrostat Cuts Blood Pressure in Phase 3 Trial of Hard-to-Treat Hypertension

AstraZeneca plans near-term regulatory filings following NEJM publication at the ESC meeting.

Stories older than 24h

Pharmacies Curtail Covid Vaccines in 16 States as Confusion Over Federal Guidance Disrupts Access

Major Trial Finds Sinus Surgery Outperforms Antibiotics for Chronic Rhinosinusitis

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

UK Mounjaro Orders Frozen Ahead of Price Hike as Korea Confronts Soaring Wegovy Use

Monthly Oral PrEP Candidate MK-8527 Shows Early Promise in Merck Study

FDA Suspends Valneva’s Ixchiq Chikungunya Vaccine Over Safety Reports

IBM and AMD Team Up on Quantum-Centric Supercomputing

New Systematic Review Links Prenatal Acetaminophen Use to Higher Autism and ADHD Risk

GLP-1 Drugs Linked to Lower Overall Cancer Risk in JAMA Oncology Analysis

FDA Approves Ionis’ Dawnzera to Prevent Hereditary Angioedema Attacks

Paclitaxel Reengineered Into Self-Assembling Nanovesicle Shows Strong Preclinical Gains

JAMA Study Finds Most U.S. Drug Plants Located in Disaster-Hit Areas, Exposing Supply Risks

Stanford Spray-Drying Method Could Turn Many IV Biologics Into Quick Injections

Viking’s Oral Obesity Pill Shows Strong Weight Loss but High Dropouts, Triggering Stock Rout

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

European Commission Approves Ogsiveo as First Therapy for Desmoid Tumors

Stanford Demonstrates Sugar-Stabilized Liposomes for Ultrasound-Controlled Drug Release

FDA Approves First New Fibromyalgia Treatment in 15 Years